Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

The objective of this study was to evaluate biological disease-modifying anti-rheumatic drugs (bDMARDs) survival in several therapy courses of patients affected by psoriatic arthritis (PsA) and to compare tumor necrosis factor inhibitors (TNFi) and non-TNFi retention rates. A total of 241 bDMARD th...

Full description

Bibliographic Details
Main Authors: M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali
Format: Article
Language:English
Published: PAGEPress Publications 2023-07-01
Series:Reumatismo
Subjects:
Psoriatic arthritis
retention rate
TNF inhibitors
anti-IL17
anti-IL12/23
Online Access:https://www.reumatismo.org/index.php/reuma/article/view/1544

Internet

https://www.reumatismo.org/index.php/reuma/article/view/1544

Similar Items